PRLD Prelude Therapeutics Inc
Healthcare · Market cap: $275.3M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $42.3K | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $146.0K | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $10.1M | $81.3K |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $225.7K | $0 |
| 2025-Q1 | $648.7K | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $25.0M | $0 |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $0 |
Bought$36.3M29 buy days
Sold$911.5K3 sell days
Net insider flow+$35.4Mnet buying · 5 years
Latest trade2026-04-21ORBIMED ADVISORS LLC
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-04-21 | Buy | ORBIMED ADVISORS LLC | Director | 2,815,315 | $4.44 | $12.5M | 2 |
| 2026-04-21 | Buy | Bonita David P | Director | 2,815,315 | $4.44 | $12.5M | 2 |
| 2025-03-25 | Buy | Vaddi Krishna | CEO | 675,000 | $0.69 | $465.7K | 1 |
| 2025-03-25 | Buy | Combs Andrew | Other C-suite | 100,000 | $0.69 | $69.0K | 1 |
| 2025-03-21 | Buy | Vaddi Krishna | CEO | 15,000 | $0.73 | $11.0K | 1 |
| 2025-03-20 | Buy | Vaddi Krishna | CEO | 5,416 | $0.73 | $4.0K | 1 |
| 2025-03-17 | Buy | Vaddi Krishna | CEO | 9,106 | $0.75 | $6.8K | 1 |
| 2025-03-14 | Buy | Vaddi Krishna | CEO | 29,999 | $0.75 | $22.5K | 1 |
| 2025-03-13 | Buy | Vaddi Krishna | CEO | 50,000 | $0.72 | $36.0K | 1 |
| 2025-03-12 | Buy | Vaddi Krishna | CEO | 47,500 | $0.71 | $33.7K | 1 |
| 2024-12-31 | Buy | Vaddi Krishna | CEO | 5,000 | $1.21 | $6.0K | 1 |
| 2024-12-30 | Buy | Vaddi Krishna | CEO | 10,000 | $1.20 | $12.0K | 1 |
| 2024-12-23 | Buy | Combs Andrew | Other C-suite | 60,000 | $1.37 | $82.2K | 1 |
| 2024-12-20 | Buy | Combs Andrew | Other C-suite | 3,075 | $1.15 | $3.5K | 1 |
| 2024-12-19 | Buy | Lim Bryant David | CFO | 25,000 | $0.91 | $22.8K | 1 |
| 2024-12-19 | Buy | Vaddi Krishna | CEO | 6,888 | $0.89 | $6.1K | 1 |
| 2024-12-18 | Buy | Vaddi Krishna | CEO | 100,000 | $0.93 | $93.0K | 1 |
| 2023-05-25 | Buy | Vaddi Krishna | CEO | 900 | $5.31 | $4.8K | 1 |
| 2023-05-24 | Buy | Lim Bryant David | Other C-suite | 2,400 | $5.39 | $12.9K | 1 |
| 2023-05-24 | Buy | Vaddi Krishna | CEO | 1,000 | $5.01 | $5.0K | 1 |
| 2023-05-23 | Buy | Vaddi Krishna | CEO | 11,856 | $5.63 | $66.7K | 1 |
| 2023-05-23 | Buy | Chardonnet Laurent | CFO | 5,000 | $5.50 | $27.5K | 1 |
| 2023-05-22 | Buy | ORBIMED ADVISORS LLC | Director | 869,565 | $5.75 | $5.0M | 1 |
| 2023-05-22 | Buy | Bonita David P | Director | 869,565 | $5.75 | $5.0M | 1 |
| 2023-04-06 | Sell | Huang Jane | President | 13,280 | $6.12 | $81.3K | 1 |
| 2022-12-20 | Buy | Vaddi Krishna | CEO | 19,188 | $5.13 | $98.4K | 1 |
| 2022-12-08 | Buy | Chardonnet Laurent | CFO | 10,000 | $4.76 | $47.6K | 1 |
| 2022-06-01 | Buy | Chardonnet Laurent | CFO | 10,000 | $4.23 | $42.3K | 1 |
| 2021-12-15 | Sell | Morosini Deborah | Other C-suite | 28,751 | $13.00 | $373.8K | 1 |
| 2021-12-14 | Buy | Combs Andrew | EVP / SVP | 4,000 | $11.60 | $46.4K | 1 |
| 2021-12-13 | Buy | Combs Andrew | EVP / SVP | 4,000 | $12.12 | $48.5K | 1 |
| 2021-11-16 | Sell | Morosini Deborah | Other C-suite | 28,751 | $15.88 | $456.5K | 2 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Bonita David P | Director | $17.5M | $0 | 2026-04-21 |
| ORBIMED ADVISORS LLC | Director | $17.5M | $0 | 2026-04-21 |
| Vaddi Krishna | CEO | $871.9K | $0 | 2025-03-25 |
| Morosini Deborah | Other C-suite | $0 | $830.3K | 2021-12-15 |
| Combs Andrew | Other C-suite | $249.6K | $0 | 2025-03-25 |
| Chardonnet Laurent | CFO | $117.4K | $0 | 2023-05-23 |
| Huang Jane | President | $0 | $81.3K | 2023-04-06 |
| Lim Bryant David | CFO | $35.7K | $0 | 2024-12-19 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2024-12-18 → 2024-12-31 | 3 | $225.7K | 55 | -13.6% (-11.9% raw) | -30.8% (-40.9% raw) | -37.0% (-38.5% raw) | closed |
| 2023-05-22 → 2023-05-25 | 5 | $10.1M | 62 | -17.3% (-11.3% raw) | -29.9% (-23.1% raw) | -41.2% (-37.9% raw) | closed |
| 2020-09-25 → 2020-09-29 | 7 | $77.3M | 50 | +23.4% (+22.5% raw) | +153.4% (+165.6% raw) | +24.1% (+45.2% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.